» Articles » PMID: 16474402

Molecular Recognition of P53 and MDM2 by USP7/HAUSP

Overview
Date 2006 Feb 14
PMID 16474402
Citations 156
Authors
Affiliations
Soon will be listed here.
Abstract

The ubiquitin-specific protease, USP7, has key roles in the p53 pathway whereby it stabilizes both p53 and MDM2. We show that the N-terminal domain of USP7 binds two closely spaced 4-residue sites in both p53 and MDM2, falling between p53 residues 359-367 and MDM2 residues 147-159. Cocrystal structures with USP7 were determined for both p53 peptides and for one MDM2 peptide. These peptides bind the same surface of USP7 as Epstein-Barr nuclear antigen-1, explaining the competitive nature of the interactions. The structures and mutagenesis data indicate a preference for a P/AXXS motif in peptides that bind USP7. Contacts made by serine are identical and crucial for all peptides, and Trp165 in the peptide-binding pocket of USP7 is also crucial. These results help to elucidate the mechanism of substrate recognition by USP7 and the regulation of the p53 pathway.

Citing Articles

USP7 V517F mutation as a mechanism of inhibitor resistance.

Miao Y, Fan F, Cheng Y, Jia L, Song S, Huan X Nat Commun. 2025; 16(1):2526.

PMID: 40087304 DOI: 10.1038/s41467-025-56981-w.


Ubiquitin specific protease 7 is a potential therapeutic target for gastric cancer.

Wang Z, Kang W, Yu R Front Oncol. 2025; 15:1530924.

PMID: 40061891 PMC: 11885118. DOI: 10.3389/fonc.2025.1530924.


USP7 Inhibitors Destabilize EBNA1 and Suppress Epstein-Barr Virus Tumorigenesis.

Chen C, Addepalli K, Soldan S, Castro-Munoz L, Preston-Alp S, Patel R J Med Virol. 2025; 97(1):e70168.

PMID: 39821265 PMC: 11740287. DOI: 10.1002/jmv.70168.


TRIM37 employs peptide motif recognition and substrate-dependent oligomerization to prevent ectopic spindle pole assembly.

Bellaart A, Brambila A, Xu J, Mendez Diaz F, Deep A, Anzola J bioRxiv. 2024; .

PMID: 39416052 PMC: 11482875. DOI: 10.1101/2024.10.09.617493.


USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53.

Li X, Pan J, Zheng P Front Oncol. 2024; 14:1427663.

PMID: 39346740 PMC: 11427698. DOI: 10.3389/fonc.2024.1427663.